| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Expression of inducible nitric oxide synthase in human breast cancer depends on tumor grade
|
Walter Tschugguel
|
|
1999
|
56 |
2 |
p. 143-149
7 p.
|
artikel
|
| 2 |
Expression of inducible nitric oxide synthase in human breast cancer depends on tumor grade
|
Tschugguel, Walter
|
|
1999
|
56 |
2 |
p. 143-149
|
artikel
|
| 3 |
G1S transition defects occur in most breast cancers and predict outcome
|
Niels Hilmer Nielsen
|
|
1999
|
56 |
2 |
p. 103-110
8 p.
|
artikel
|
| 4 |
G1‐S transition defects occur in most breast cancers and predict outcome
|
Nielsen, Niels Hilmer
|
|
1999
|
56 |
2 |
p. 103-110
|
artikel
|
| 5 |
Hsp27 overexpression inhibits doxorubicininduced apoptosis in human breast cancer cells
|
Rhonda K. Hansen
|
|
1999
|
56 |
2 |
p. 185-194
10 p.
|
artikel
|
| 6 |
Hsp27 overexpression inhibits doxorubicin–induced apoptosis in human breast cancer cells
|
Hansen, Rhonda K.
|
|
1999
|
56 |
2 |
p. 185-194
|
artikel
|
| 7 |
Immunohistochemical labelling for prostatespecific antigen in breast carcinomas
|
Kalle A. Alanen
|
|
1999
|
56 |
2 |
p. 167-174
8 p.
|
artikel
|
| 8 |
Immunohistochemical labelling for prostate–specific antigen in breast carcinomas
|
Alanen, Kalle A.
|
|
1999
|
56 |
2 |
p. 167-174
|
artikel
|
| 9 |
Metaanalysis of trials comparing toremifene with tamoxifen and factors predicting outcome of antiestrogen therapy in postmenopausal women with breast cancer
|
S. Pyrhönen
|
|
1999
|
56 |
2 |
p. 131-141
11 p.
|
artikel
|
| 10 |
Meta‐analysis of trials comparing toremifene with tamoxifen and factors predicting outcome of antiestrogen therapy in postmenopausal women with breast cancer
|
Pyrhönen, S.
|
|
1999
|
56 |
2 |
p. 131-141
|
artikel
|
| 11 |
Overexpression of basic fibroblast growth factor (FGF2) downregulates Bcl2 and promotes apoptosis in MCF7 human breast cancer cells
|
Paul Maloof
|
|
1999
|
56 |
2 |
p. 151-165
15 p.
|
artikel
|
| 12 |
Overexpression of basic fibroblast growth factor (FGF–2) downregulates Bcl–2 and promotes apoptosis in MCF–7 human breast cancer cells
|
Maloof, Paul
|
|
1999
|
56 |
2 |
p. 151-165
|
artikel
|
| 13 |
PACAP (638) is a PACAP receptor antagonist for breast cancer cells
|
Julius Leyton
|
|
1999
|
56 |
2 |
p. 175-184
10 p.
|
artikel
|
| 14 |
PACAP (6–38) is a PACAP receptor antagonist for breast cancer cells
|
Leyton, Julius
|
|
1999
|
56 |
2 |
p. 175-184
|
artikel
|
| 15 |
Postoperative chemoendocrine treatment with mitomycin C, tamoxifen, and UFT is effective for patients with premenopausal estrogen receptorpositive stage II breast cancer
|
Keizo Sugimachi
|
|
1999
|
56 |
2 |
p. 111-122
12 p.
|
artikel
|
| 16 |
Postoperative chemo–endocrine treatment with mitomycin C, tamoxifen, and UFT is effective for patients with premenopausal estrogen receptor–positive stage II breast cancer
|
Sugimachi, Keizo
|
|
1999
|
56 |
2 |
p. 111-122
|
artikel
|
| 17 |
Three new active cisplatincontaining combinations in the neoadjuvant treatment of locally advanced and locally recurrent breast carcinoma: a randomized phase II trial
|
Giorgio Cocconi
|
|
1999
|
56 |
2 |
p. 123-130
8 p.
|
artikel
|
| 18 |
Three new active cisplatin‐containing combinations in the neoadjuvant treatment of locally advanced and locally recurrent breast carcinoma: a randomized phase II trial
|
Cocconi, Giorgio
|
|
1999
|
56 |
2 |
p. 123-130
|
artikel
|
Tijdschrift beschrijving